Literature DB >> 3953507

Extraskeletal myxoid chondrosarcoma arising from the retroperitoneum.

T Fukuda, H Ishikawa, Y Ohnishi, S Tachikawa, S Onizuka, I Sakashita.   

Abstract

A case of extraskeletal myxoid chondrosarcoma is presented. The tumor occurred in the retroperitoneum and systemic metastases were found at autopsy. The primary and metastatic tumors were soft and strikingly myxoid on gross appearance. Microscopic observation revealed undifferentiated malignant tumor having large amounts of myxoid substance and a small amount of well-differentiated chondrosarcoma element in the primary lesions. The authors obtained an immunohistochemical result that the tumor cells showed positivity for alpha-1-antitrypsin and alpha-1-antichymotrypsin. Regarding S-100 protein, the well-differentiated chondrosarcoma element revealed intense positivity, whereas the poorly differentiated myxoid areas were not positive except for a few tumor cells. This is the first case, to our knowledge, of extraskeletal myxoid chondrosarcoma arising from the retroperitoneum, and immunohistologic findings suggest that alpha-1-antitrypsin and alpha-1-antichymotrypsin may be available markers in poorly differentiated chondrosarcomas showing a negative reaction for S-100 protein.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3953507     DOI: 10.1093/ajcp/85.4.514

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  3 in total

1.  Primary intracranial extraskeletal myxoid chondrosarcoma: A case report and review of literature.

Authors:  Zi-You Zhu; Yu-Bo Wang; Han-Yi Li; Xin-Min Wu
Journal:  World J Clin Cases       Date:  2022-05-06       Impact factor: 1.534

2.  Parachordoma: an ultrastructural and immunohistochemical study.

Authors:  T Ishida; H Oda; T Oka; T Imamura; R Machinami
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

3.  Extraskeletal myxoid chondrosarcoma of the vulva: A case report.

Authors:  Alisa Villert; Larisa Kolomiets; Nikolay Vasilyev; Vladimir Perelmuter; Olga Savenkova
Journal:  Oncol Lett       Date:  2015-08-11       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.